Literature DB >> 10996112

Cytomegalovirus DNA detection in Guthrie cards: a powerful tool for diagnosing congenital infection.

M Barbi1, S Binda, V Primache, S Caroppo, P Didò, P Guidotti, C Corbetta, D Melotti.   

Abstract

BACKGROUND: A simple and reliable diagnosis of congenital cytomegalovirus infection is necessary both for clinical and epidemiological purposes. This could be accomplished through the demonstration of cytomegalovirus (CMV) DNA in blood spots (DBS) on Guthrie cards.
OBJECTIVES: (1) To assess the sensitivity and specificity of the method (DBS test) in diagnosing congenital CMV infection compared with viral isolation and (2) to evaluate the applications of the test to the late diagnosis of congenital CMV. STUDY
DESIGN: The method was tested on the cards of (1) 509 babies examined through viral isolation within their third week of life (72 positive cases) and (2) 191 children studied after 3 weeks of life (25 days to 5 years). Blood was eluted from Guthrie cards and heat extracted. The products of a nested polymerase chain reaction (PCR) amplifying one region in the CMV glycoprotein B (gB) gene were detected by agarose gel electrophoresis.
RESULTS: DBS test was positive in all 72 congenitally infected babies and in four of the 437 negative at cytomegalovirus isolation (sensitivity 100%, specificity 99%). Infection in 16 of the 92 infants with a late viral isolation was demonstrated to be congenital by the test, which also detected congenital infection in 18 of 83 children in whom viral culture was not performed (13 with and five without symptoms). Fifty-six additional control cases tested negative.
CONCLUSIONS: DBS test is a reliable assay for diagnosing congenital cytomegalovirus infection and could be used as an alternative to viral culture. It is able to reveal whether ascertained CMV infection is congenital or postnatal at an age when viral isolation is not able to do so. It can assess the role of risky procedures such as transfusion and it can ascertain the etiology of morbid conditions diagnosed late or of controversial origin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996112     DOI: 10.1016/s1386-6532(00)00089-5

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  29 in total

1.  Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.

Authors:  Suresh B Boppana; Shannon A Ross; Masako Shimamura; April L Palmer; Amina Ahmed; Marian G Michaels; Pablo J Sánchez; David I Bernstein; Robert W Tolan; Zdenek Novak; Nazma Chowdhury; William J Britt; Karen B Fowler
Journal:  N Engl J Med       Date:  2011-06-02       Impact factor: 91.245

2.  Evaluation of cytomegalovirus (CMV) DNA quantification in dried blood spots: retrospective study of CMV congenital infection.

Authors:  Christelle Vauloup-Fellous; Aurélie Ducroux; Vincent Couloigner; Sandrine Marlin; Olivier Picone; Julie Galimand; Natalie Loundon; Françoise Denoyelle; Liliane Grangeot-Keros; Marianne Leruez-Ville
Journal:  J Clin Microbiol       Date:  2007-09-26       Impact factor: 5.948

3.  Real-time PCR assay using specimens on filter disks as a template for detection of cytomegalovirus in urine.

Authors:  Naoki Nozawa; Shin Koyano; Yumiko Yamamoto; Yuhki Inami; Ichiro Kurane; Naoki Inoue
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

4.  Development of multiplex PCRs for detection of common viral pathogens and agents of congenital infections.

Authors:  C J McIver; C F H Jacques; S S W Chow; S C Munro; G M Scott; J A Roberts; M E Craig; W D Rawlinson
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Comparison of DNA extraction methods from small samples of newborn screening cards suitable for retrospective perinatal viral research.

Authors:  Gai L McMichael; Amanda R Highet; Catherine S Gibson; Paul N Goldwater; Michael E O'Callaghan; Emily R Alvino; Alastair H MacLennan
Journal:  J Biomol Tech       Date:  2011-04

Review 6.  Should hearing targeted screening for congenital cytomegalovirus infection Be implemented?

Authors:  Travis Haller; Angela Shoup; Albert H Park
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2020-04-23       Impact factor: 1.675

7.  Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection.

Authors:  Suresh B Boppana; Shannon A Ross; Zdenek Novak; Masako Shimamura; Robert W Tolan; April L Palmer; Amina Ahmed; Marian G Michaels; Pablo J Sánchez; David I Bernstein; William J Britt; Karen B Fowler
Journal:  JAMA       Date:  2010-04-14       Impact factor: 56.272

Review 8.  Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature.

Authors:  Michael A Gaytant; G Ingrid J G Rours; Eric A P Steegers; Jochem M D Galama; Ben A Semmekrot
Journal:  Eur J Pediatr       Date:  2003-02-13       Impact factor: 3.183

9.  Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay.

Authors:  Yoshiko Fukui; Keiko Shindoh; Yumiko Yamamoto; Shin Koyano; Isao Kosugi; Toyofumi Yamaguchi; Ichiro Kurane; Naoki Inoue
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

Review 10.  Detection of congenital cytomegalovirus in newborns using nucleic acid amplification techniques and its public health implications.

Authors:  Guoyu Liu; Rong Hai; Fenyong Liu
Journal:  Virol Sin       Date:  2017-10-30       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.